BioFuels Journal

Englewood, CO - March 29, 2016 - Gevo, Inc. (NASDAQ:GEVO), a leading renewable chemicals and next-generation biofuels company, announced today that it has priced its underwritten public offering of common stock and warrants.

Gevo announced that it has agreed to sell 3,721,429 Series C units, with each Series C unit consisting of one share of common stock, one Series F warrant to purchase one share of common stock and two Series H warrants, each to purchase one share of common stock, at a public offering price of $0.35 per Series C unit.

Gevo has also agreed to sell 6,571,429 Series D units, with each Series D unit consisting of a pre-funded Series G warrant to purchase one share of common stock, one Series F warrant to purchase one share of common stock and two Series H warrants, each to purchase one share of common stock, at a public offering price of $0.34 per Series D unit.

The Series F warrants will have an exercise price of $0.35 per share, be exercisable beginning on October 1, 2016 and will expire on April 1, 2021.

The Series G warrants will have an exercise price of $0.35 per share, which will be pre-paid upon issuance, except for a nominal exercise price of $0.01 per share and, consequently, no additional payment or other consideration (other than the nominal exercise price of $0.01 per share) will be required to be delivered to the Company by the holder upon exercise of the Series G warrants.

The Series G warrants will be exercisable from the date of original issuance and will expire on April 1, 2017.

The Series H warrants will have an exercise price of $0.75 per share, be exercisable beginning on the date of original issuance and will expire on October 1, 2016.

The shares of common stock and the warrants will be immediately separable and will be issued separately.

The gross proceeds to Gevo from this offering are expected to be approximately $3.5 million not including any future proceeds from the exercise of the warrants.

Gevo currently intends to use the net proceeds from the offering, excluding any future proceeds from the exercise of the warrants, to fund working capital and for other general corporate purposes.

In connection with the offering, Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, is acting as sole book-running manager.

The offering of shares of common stock and warrants was made pursuant to Gevo’s shelf registration statement filed with the Securities and Exchange Commission (SEC) and declared effective, and is expected to close on or about April 1, 2016, subject to customary closing conditions.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

For more information, please contact David Rodewald at 805-494-9508 or [email protected]

See Related Websites/Articles:

• Gevo, Inc.

more ETHANOL...